BETAFERON

This brand name is authorized in Australia, Brazil, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United Kingdom, South Africa

Active ingredients

The drug BETAFERON contains one active pharmaceutical ingredient (API):

1 Interferon beta-1b, recombinant
UNII TTD90R31WZ - INTERFERON BETA-1B

Interferon beta-1b has been shown to possess both antiviral and immunoregulatory activity. The mechanisms by which interferon beta-1b exerts its actions in multiple sclerosis are not clearly understood. However, it is known that the biological response-modifying properties of interferon beta-1b are mediated through its interactions with specific cell receptors found on the surface of human cells.

Read about Interferon beta-1b

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L03AB08 Interferon beta-1b L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AB Interferons
Discover more medicines within L03AB08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 8101J
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 538912040011712
Country: EE Ravimiamet Identifier(s): 1071245, 1205457, 1397550, 1397561, 1461057, 1461068, 1662667
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 95003005, 95003005IP1
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 134546
Country: FR Base de données publique des médicaments Identifier(s): 64488861
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 367626, 45123
Country: HK Department of Health Drug Office Identifier(s): 47987
Country: IE Health Products Regulatory Authority Identifier(s): 88001, 89116
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6119
Country: JP 医薬品医療機器総合機構 Identifier(s): 6399416D1033
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1027712, 1027713, 1036694, 1036695, 1056536, 1056537, 1061960, 1061961, 1077761
Country: NL Z-Index G-Standaard, PRK Identifier(s): 83879, 90425
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 7487
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100112530
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W63878007
Country: SG Health Sciences Authority Identifier(s): 11228P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 12853031H
Country: ZA Health Products Regulatory Authority Identifier(s): 30/34/0185

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.